Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients.
about
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical applicationTransplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential StrategiesProgress and obstacles towards generating hematopoietic stem cells from pluripotent stem cellsHematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.Experimental approaches to derive CD34+ progenitors from human and nonhuman primate embryonic stem cellsA paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retrovirusesIdentification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.Hemato-endothelial differentiation from lentiviral-transduced human embryonic stem cells retains durable reporter gene expression under the control of ubiquitin promoter.In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells.Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.In vivo generation of beta-cell-like cells from CD34(+) cells differentiated from human embryonic stem cells.In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cellsReconstructing blood from induced pluripotent stem cells.Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.Effects of long-term culture on human embryonic stem cell aging.SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cellsDeciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cellsDifferentiation of neural lineage cells from human pluripotent stem cells.Concepts for the clinical use of stem cells in equine medicine.Regulatory issues for personalized pluripotent cells.Phenotypic changes of human cells in human-rat liver during partial hepatectomy-induced regeneration.A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.Concise Review: Getting to the Core of Inherited Bone Marrow Failures.Pluripotent stem cell-derived natural killer cells for cancer therapy.Hematopoietic differentiation from human ESCs as a model for developmental studies and future clinical translations. Invited review following the FEBS Anniversary Prize received on 5 July 2009 at the 34th FEBS Congress in Prague.Prospects and challenges of reprogrammed cells in hematology and oncology.Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells.Manipulation of hematopoietic stem cells for regenerative medicine.Diverse hematopoietic potentials of five human embryonic stem cell lines.OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells.Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy.Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.Multiorgan engraftment of human somatic cells in swine foetuses after intra-blastocyst transplantation.
P2860
Q26748949-8B0200C3-8709-4CF7-9E7D-4AB7113BAA37Q26752512-AD49D3AA-E06D-4773-95AF-2C863E91EE47Q26824479-DB31E879-1591-4569-B1BF-CF78B6FD4EB5Q26851475-F7A0D968-262D-4A13-9CC0-871472AC31F6Q27026573-180ED806-C0B0-44C0-99FA-202929F6706EQ28756753-CF689FBA-0071-4F16-8955-922D0A004376Q30525434-0E77A1A5-210D-4D6D-81D5-4ACDFEF3D892Q33541890-9D3737EC-265C-4AE5-B155-4BC3713B91D3Q33647732-F2A0CE88-CC8E-4CB0-B194-3D92C9011257Q33787406-5E5668C9-F697-423B-88E5-DF09AE8090EFQ33801849-B7D2514E-FBAC-4FD7-9080-D82615CA8DC7Q33893493-F3D657AD-CDA0-4A4B-8B6A-D23B296507C1Q34034653-64ADA71E-D630-4882-85C3-EEF765C81EDDQ34038572-21DD51AE-685F-4941-A792-AD9DE41CCD71Q34125345-7328B2C3-7E05-4FBE-9896-401B0CE051BFQ34175573-922FACE7-63BB-4401-B68C-C0D8526EC77CQ34382978-B860B3D1-6A1D-4743-A562-5354F8BDC98DQ34485779-488993ED-32D0-46F6-A503-346744EE8BF5Q36085355-E6F5B7FC-97B8-43FB-B79E-297A296482D1Q36436582-A2869D6B-7382-4F7A-9789-8FA1DE6B607AQ36724256-BD72FEB7-3C0B-4683-BE40-EB7767F2E7AAQ36860971-5FD834BE-24B3-497E-A883-6B5021D1C32CQ36909143-68375F39-CA19-461D-AF24-45802F3207F3Q37217497-C54E617E-3264-4BD1-8505-2D6554661BFDQ37290303-4F09625F-F50F-4679-8FB1-AB6D436AA312Q37299126-E439A803-9B10-451B-B559-54017F77819BQ37398305-3B415D9D-849E-4046-9D5D-FEB6FFCA5F8EQ37633372-90FCE898-5783-409B-8E63-DC8896D88BE4Q37783804-D305DFF4-3C95-4109-B9DF-1E4E6E0FF1C2Q37810643-C205E377-497A-452A-B9FD-BB4A3DBD5E43Q38031618-C3AE5255-AF70-486F-BF2A-60464242654AQ38035454-B53566D6-38DE-40D2-A13C-51676BD42849Q38167666-AFE81255-2265-44B4-A033-EA1CD1BD8B6FQ39952089-64FD5A29-C581-40B5-ACC2-0A99B0CCC61BQ39955435-77F5D9A0-D6AD-421A-BB3D-930341848D4EQ40258263-946A25B4-4B19-4D2C-824D-B010642013CBQ40290383-AFA1C121-F74D-44BB-A9F3-FF7328342673Q43066137-AE82A4C1-13D8-4544-9F45-93C2136C2DF8Q54401061-E3E0BDB7-436D-45AA-8931-F6FB68E1B7EE
P2860
Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@en
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@nl
type
label
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@en
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@nl
prefLabel
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@en
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@nl
P2093
P2860
P1433
P1476
Human embryonic stem cell-deri ...... ondary fetal sheep recipients.
@en
P2093
A Daisy Narayan
Dan S Kaufman
James A Thomson
Jessica L Chase
Rachel L Lewis
Xinghui Tian
P2860
P304
P356
10.1182/BLOOD-2005-05-1922
P407
P577
2005-11-08T00:00:00Z